Avery J Lam

Cited by

	All	Since 2019
Citations	260	248
h-index	7	7
i10-index	6	6

201720182019202020212022202320244 7 33 21 38 64 62 29

Public access

View all

11 articles

1 article

available

not available

Based on funding mandates

Co-authors

Megan K. LevingsUniversity of British ColumbiaVerified email at ubc.ca
Anne M PesenackerUCL Institute of Immunity and TransplantationVerified email at ucl.ac.uk
Romy HoeppliUniversity of British ColumbiaVerified email at alumni.ubc.ca
Katherine N MacDonaldBiomedical Engineering, University of British ColumbiaVerified email at alumni.ubc.ca
Michael S. KoborProfessor and Canada Research Chair in Social Epigenetics, University of British ColumbiaVerified email at cmmt.ubc.ca
John D. RiouxProfessor of Medicine, Université de Montréal and the Montreal Heart InstituteVerified email at umontreal.ca
Manjurul HaquePostdoctoral fellowVerified email at mail.mcgill.ca
Dan WuUniversity of British ColumbiaVerified email at alumni.ubc.ca
Nicholas AJ DawsonZymeworksVerified email at zymeworks.com
Dominic BoardmanAstraZenecaVerified email at astrazeneca.com
Kirsten A. Ward-HartstongeUniversity of OtagoVerified email at bcchr.ca
Laura CookThe University of MelbourneVerified email at unimelb.edu.au
Ramon I Klein GeltinkAssistant Professor, Department of Pathology and Laboratory Medicine, Faculty of Medicine, University of British ColumbiaVerified email at bcchr.ca
Christine M WardellUniversity of British Columbia and BC Children's Hospital Research InstituteVerified email at bcchr.ca
Alexandra NewtonUniversity of California San DiegoVerified email at ucsd.edu
David T S LinAbCellera Biologics

Avery J Lam

Postdoctoral Fellow, Stanford University

Verified email at stanford.edu - Homepage

human immunology regulatory T cells cell therapy genome editing


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Helios is a marker, not a driver, of human Treg stability AJ Lam, P Uday, JK Gillies, MK Levings European Journal of Immunology 52 (1), 75-84, 2022	47	2022
Harnessing advances in T regulatory cell biology for cellular therapy in transplantation AJ Lam, RE Hoeppli, MK Levings Transplantation 101 (10), 2277-2287, 2017	44	2017
Optimized CRISPR-mediated gene knockin reveals FOXP3-independent maintenance of human Treg identity AJ Lam, DTS Lin, JK Gillies, P Uday, AM Pesenacker, MS Kobor, ... Cell Reports 36 (5), 2021	42	2021
Innate control of tissue-reparative human regulatory T cells AJ Lam, KN MacDonald, AM Pesenacker, SC Juvet, KA Morishita, ... The Journal of Immunology 202 (8), 2195-2209, 2019	41	2019
Characterization of regulatory T cells in obese omental adipose tissue in humans D Wu, JM Han, X Yu, AJ Lam, RE Hoeppli, AM Pesenacker, Q Huang, ... European Journal of Immunology 49 (2), 336-347, 2019	41	2019
Janus and PI3-kinases mediate glucocorticoid resistance in activated chronic leukemia cells S Oppermann, AJ Lam, S Tung, Y Shi, L McCaw, G Wang, J Ylanko, ... Oncotarget 7 (45), 72608, 2016	17	2016
An optimized method to measure human FOXP3+ regulatory T cells from multiple tissue types using mass cytometry NAJ Dawson, AJ Lam, L Cook, RE Hoeppli, R Broady, AM Pesenacker, ... European Journal of Immunology 48 (8), 1415-1419, 2018	8	2018
PTEN is required for human Treg suppression of costimulation in vitro AJ Lam, M Haque, KA Ward‐Hartstonge, P Uday, CM Wardell, JK Gillies, ... European Journal of Immunology 52 (9), 1482-1497, 2022	7	2022
Suppression of human dendritic cells by regulatory T cells Q Huang, AJ Lam, DA Boardman, NAJ Dawson, MK Levings Bio-protocol 11 (21), e4217-e4217, 2021	5	2021
PHLPP signaling in immune cells G Lordén, AJ Lam, MK Levings, AC Newton PI3K and AKT Isoforms in Immunity: Mechanisms and Therapeutic Opportunities …, 2022	4	2022
Modelling graft-versus-host disease in mice using human peripheral blood mononuclear cells M Haque, DA Boardman, AJ Lam, KN MacDonald, L Sanderink, Q Huang, ... Bio Protoc 12 (23), e4566, 2022	3	2022
Human regulatory T cell potential for tissue repair via IL-33/ST2 and amphiregulin AJ Lam, H Huang, JG Pan, SS Sidhu, G Charron, SM Ivison, JD Rioux, ... Transplantation 102, S331, 2018	1	2018
A germline heterozygous dominant negative IKZF2 variant causing syndromic primary immune regulatory disorder and ICHAD HY Lu, M Vaseghi-Shanjani, AJ Lam, M Sharma, A Mohajeri, J Gillies, ... medRxiv, 2023.09. 09.23295301, 2023		2023
Developing next-generation regulatory T cell therapeutics AJ Lam University of British Columbia, 2021		2021

The system can't perform the operation now. Try again later.

Articles 1–14

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors